2019 annual financial data
Keros Therapeutics 2019 Net margin
Direct answer
Net margin was -123.44%.
Operating income was -10.56M USD and net income was -12.34M USD.
Operating cash flow was -16M USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10M USD
- Operating income
- -10.56M USD
- Net income
- -12.34M USD
- Operating cash flow
- -16M USD